Since enhanced tumor cell migratory capacity is one of the characteristics of tumor metastasis, further tests based on loss-of-function approach were used to examine the effects of G3BP1 on RCC tumor cell mesenchymal phenotypes. This evidence concerns the gene G3BP1 and renal cell adenocarcinoma.